title: Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients.
abstract: BACKGROUND
  Left ventricular hypertrophy (LVH) is a known predictor of morbidity and mortality in patients with essential hypertension. The prevalence and significance of LVH in heart transplant recipients is unknown.
  
  
  METHODS
  Transthoracic echocardiograms were performed as part of a routine protocol 1 year after heart transplantation in 141 consecutive patients. Demographic and echocardiographic data were collected using patients' records and center-specific data from the Cardiac Transplant Research Database and analyzed to determine the prevalence and predictors of LVH at 1 year post-transplantation. Patients were divided into three groups based on left ventricular mass (LVM): normal (LVM <150 g); mild-moderate LVH (LVM 150 to 250 g); and severe LVH (LVM >250 g).
  
  
  RESULTS
  LVH was common at 1 year after heart transplantation, present in 83% of heart transplant recipients. Univariate predictors of severe LVH were increased body mass index (p < 0.01), pre-transplant diabetes mellitus (p = 0.02) and pre-transplant hypertension (p = 0.01). By multivariate analysis, pre-transplant hypertension was the only independent predictor of severe LVH (hazard ratio [HR] 2.3, 95% confidence interval [CI] 1.1 to 5.4, p = 0.05). Heart transplant recipients with severe LVH had significantly decreased survival, as compared to patients with normal LVM and mild-moderate LVH (p = 0.03). After multivariate analysis adjusting for age, race, gender, pre-transplant hypertension and diabetes, severe LVH remained a strong, independent predictor of mortality (HR 3.6, 95% CI 1.0 to 12.1, p = 0.04).
  
  
  CONCLUSIONS
  LVH is common at 1 year after heart transplantation and is a strong, independent predictor of increased mortality. Hypertension before transplantation is an independent predictor of the presence of severe LVH at 1 year after heart transplantation.
authors.affiliation: Division of Cardiology, Department of Medicine, Medical University of South Carolina and Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina 29425, USA.
authors.forename: Randy
authors.initials: R
authors.lastname: Goodroe
authors.forename: D Dirk
authors.initials: DD
authors.lastname: Bonnema
authors.forename: Shayna
authors.initials: S
authors.lastname: Lunsford
authors.forename: Phillip
authors.initials: P
authors.lastname: Anderson
authors.forename: Barbara
authors.initials: B
authors.lastname: Ryan-Baille
authors.forename: Walt
authors.initials: W
authors.lastname: Uber
authors.forename: John
authors.initials: J
authors.lastname: Ikonomidis
authors.forename: Arthur J
authors.initials: AJ
authors.lastname: Crumbley
authors.forename: Adrian
authors.initials: A
authors.lastname: VanBakel
authors.forename: Michael R
authors.initials: MR
authors.lastname: Zile
authors.forename: Naveen
authors.initials: N
authors.lastname: Pereira
mesh_terms: D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects* / Q000401:mortality*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011379:Prognosis; D012720:Severity of Illness Index; D013997:Time Factors